You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞通窩輪》【瑞通認股證牛熊證】恆指先跌後重上29400點 阿里、平保業續後資金追好倉 恆指牛55313 熊55685/ 阿里牛52140 熊55539/ 平保牛60008 熊61264
阿思達克 02-04 10:49
道指隔晚收報30723點,升36點(或0.1%)。恆指上日盤中曾跌穿29000點關,收市轉升58點(或0.2%),報29307點,連升三日累漲逾1000點。今早回吐逾200點後跌幅收窄並回升,29300點失而復得。恆指好倉(牛證及認購權證)昨淨流入近2300萬港元(下同),恆指淡倉(熊證及認沽權證)同日淨流出逾2500萬元,反映投資者預期大市將調整。昨日恆指牛證街貨重貨區為收回價27800至27899點,而熊證街貨重貨區為收回價30000至30099點。

阿里巴巴(09988)上季業績勝預期,獲部份券商調高目標價,但阿里昨大部分時間受壓,曾下滑近5%至247.2元,直至臨近收市一度急彈上266元,收升0.4%於261元,連升三日。外電引述市場消息指,阿里旗下螞蟻集團和中國監管機構達成重組共識,螞蟻將由金融科技公司變成金融控股公司,接受更高資本要求。據報螞蟻集團整改計劃將在農曆新年假期前公佈,消息紓緩市場部份憂慮,不過阿里今早先回落逾1%,跌穿258元,其後轉升。昨有近6000萬元淨流入其好倉,淡倉同日則有逾730萬元淨流出。

中國平安(02318)公佈截至去年底止,全年純利1430.99億元人民幣,按年跌4.2%,期內新業務價值按年跌34.7%至495.75億元人民幣。平保由一月下旬反覆走弱,昨日盤中曾低見88.9元的逾兩個月低位,較上月升抵的103.6元高位累計回落逾14%,險守100天線,收市未能重返90元關口之上。平保今早升約4%,高位見93.15元。上日有逾1300萬元淨流入其好倉,淡倉同日亦有約110萬元淨流入。

藥明生物(02269)以每股112元配售1.18億股,淨籌逾131億元,不過股份上日跌至115.3元的10天線水平已見承接,全日跌幅收窄至2.33%,報117.6元,結束三日升勢。有券商看好藥明今次配股可捕捉新冠疫苗產能擴張機遇。藥明今早曾升約2%,重上120元。昨有逾20億元北水淨買入藥明。輪證資金流方面,逾1400萬元淨流入其好倉,淡倉同日則有小量資金淨流出。

主要產油國遵守減產承諾,加上市場預料美國國會快將通過刺激經濟方案,刺激國際油價創一年高位,中海油(00883)上日漲3.55%,收報8.46元,突破250天線,連升三日累漲11%。有券商重申中海油「買入」評級,料未來公司將透露更多減碳計劃,並受惠於高油價。中海油今早曾再升近3%,升穿8.7元。上日有逾18億元北水淨買入中海油。輪證資金流方面,逾1400萬元淨流出其好倉,淡倉同日則有逾30萬元淨流入。

瑞通相關認股證之選擇:

恆指輕微價外、中年期購22836,行使價:32000點,2021年10月到期,實際槓桿:8.4倍

恆指輕微價外、中短期沽20798,行使價:26900點,2021年7月到期,實際槓桿:7.6倍

阿里輕微價外、中短期購22848,行使價:299.88元,2021年5月到期,實際槓桿:6.5倍

阿里輕微價外、中短期沽20778,行使價:225.18元,2021年5月到期,實際槓桿:6倍

平保貼價、中短期購12998,行使價:97.8元,2021年7月到期,實際槓桿:8.3倍

平保輕微價外、中短期沽19664,行使價:82.1元,2021年6月到期,實際槓桿:8.7倍

藥明輕微價外、中年期購26864,行使價:126.88元,2021年8月到期,實際槓桿:3.1倍

海油輕微價外、長期購13639,行使價:9.74元,2021年11月到期,實際槓桿:3.7倍

海油價外、中年期沽27349,行使價:6.99元,2021年9月到期,實際槓桿:4.1倍

比迪價外、中短期購29333,行使價:318.88元,2021年7月到期,實際槓桿:3.4倍

吉利輕微價外、中短期購29335,行使價:30.93元,2021年5月到期,實際槓桿:4.7倍

吉利輕微價外、中短期沽11172,行使價:24.93元,2021年6月到期,實際槓桿:3.1倍

瑞通相關牛熊證之選擇:

恆指牛證55313,收回價:28892點,槓桿比率:55.9倍

恆指熊證55685,收回價:29790點,槓桿比率:39.6倍

阿里牛證52140,收回價:240.88元,槓桿比率:10.1倍

阿里熊證55539,收回價:288.88元,槓桿比率:7.6倍

平保牛證60008,收回價:85.38元,槓桿比率:11.1倍

平保熊證61264,收回價:101.88元,槓桿比率:8倍

藥明牛證51508,收回價:104.8元,槓桿比率:6.3倍

藥明熊證59949,收回價:142.8元,槓桿比率:4.3倍

海油牛證55047,收回價:7.48元,槓桿比率:5.8倍

比迪牛證69798,收回價:234.88元,槓桿比率:7.3倍

重要風險通知

本結構性產品並無抵押品。

結構性產品之價格一般可急升亦可急跌,有可能損失結構性產品之全部或重大部分購買價,閣下對此應有所準備。

閣下投資前應了解產品風險,如有需要應諮詢專業建議。~

重要聲明:

以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account